You are here

olumiant

Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time

Marketwatch

Mon, 09/14/20 - 10:21 am

Gilead Sciences

New research from BenovelentAI supports use of Lilly’s Olumiant in COVID-19

Pharmaforum

Wed, 07/1/20 - 10:56 am

artificial intelligence

machine learning

AZ, Lilly join efforts to develop drugs for COVID-19

Pharmaforum

Tue, 04/14/20 - 09:50 am

Eli Lilly Starts Clinical Trial for Potential COVID-19 Treatment

Motley Fool

Mon, 04/13/20 - 10:54 am

clinical trials

Eli Lilly and Incyte Record Another Positive Clinical Trial for Olumiant Works in Eczema

Motley Fool

Thu, 02/13/20 - 12:12 am

clinical trials

atopic dermatitis

ICER pulls report blasting ‘marginal’ RA drugs, citing need to rethink its approach

Fierce Pharma

Wed, 10/2/19 - 11:53 am

rheumatoid arthritis

Olumiant from Lilly, Incyte clears third eczema study, but who will use it?

Endpoints

Mon, 08/26/19 - 09:29 am

Look here, FDA: Eli Lilly touts Olumiant safety data for unapproved high dose

Fierce Pharma

Wed, 06/12/19 - 06:43 pm

rheumatoid arthritis

Incyte pulls away 'damaged goods' baricitinib to focus on internal pipeline

Endpoints

Tue, 04/30/19 - 08:57 pm

Lilly and Incyte's Olumiant Hits the Mark in Two Phase III Atopic Dermatitis Trials

BioSpace

Mon, 02/4/19 - 11:49 am

atopic dermatitis

clinical trials

Upcoming events – Ascendis and Lilly hope for growth with pivotal data

EP Vantage

Fri, 02/1/19 - 11:58 am

clinical trials

pediatric growth hormone deficiency

Lilly's lupus treatment succeeds in mid-stage trial

Reuters

Thu, 06/14/18 - 09:45 am

clinical trials

Eli Lilly’s Arthritis Drug Approved at Lower Dose with Boxed Warning

Xconomy

Fri, 06/1/18 - 10:36 pm

rheumatoid arthritis

3 Biotechs With Huge FDA Decisions in June

Motley Fool

Thu, 05/31/18 - 10:00 pm

Array Biopharma

Big Week Ahead for Eli Lilly: Here's What to Look For

Motley Fool

Sun, 04/22/18 - 12:12 pm

rheumatoid arthritis

3 Biotech Stocks With Major Catalysts Incoming

Motley Fool

Fri, 04/20/18 - 12:45 pm

TG Therapeutics

Cara Therapeutics

rheumatoid arthritis

Safety Concerns Linger for Lilly’s Arthritis Drug as FDA Panel Looms

Xconomy

Fri, 04/20/18 - 09:30 am

rheumatoid arthritis

Positive momentum for biotech Incyte

GoinPharma

Thu, 03/29/18 - 09:30 pm

rheumatoid arthritis

3 Biotechs That Could Get Big Boosts in April

Motley Fool

Wed, 03/28/18 - 10:02 am

Neurocrine Biosciences

Lilly’s Olumiant, spurned by FDA, gets nod from NICE

Fierce Pharma

Sat, 07/1/17 - 09:26 am

rheumatoid arthritis

Pages